ISTA Pharmaceuticals (ISTA)
ISTA Pharmaceuticals Profit Margin: -52.35%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ISTA Profit Margin Rankings
| Overall | 7th percentile | 4071 of 4397 |
| Sector | 30th percentile | 325 of 469 in Healthcare |
| Industry | 37th percentile | 23 of 37 in Drug Manufacturers - Other |
ISTA Profit Margin Range, Past 5 Years
| Minimum | -229.0% | Mar 2011 |
| Maximum | 74.62% | Jun 2010 |
| Average | -41.84% |
About Profit Margin
Profit margin represents the percentage of revenue that a company keeps as profit after accounting for fixed and variable costs. It is calculated by dividing net income by revenue. The profit margin is mainly used for internal comparisons, because acceptable profit margins vary between industries. In general, narrow profit margins indicate increased volatility. For companies with significant fixed costs, wide profit margins reduce the risk that a decline in sales will cause a net profit loss.
Displayed as a percentage, profit margin can be thought as the amount of profit that a company keeps per dollar of revenue. For example, if a company has a profit margin of 43%, the company keeps $.43 of each dollar of revenue.
Learn More
You may also be interested in these ISTA related companies
ISTA News
ISTA Pharma (ISTA) Reports Positive Results from Phase 3 Study of PROLENSA, to File New NDA in 1H'12
Apr 23, 7:32AM Street Insider
Apr 23, 7:32AM Street Insider
Law Office of Brodsky & Smith, LLC Announces Investigation of ISTA Pharmaceuticals, Inc.
Apr 02, 5:37PM PR Newswire
Apr 02, 5:37PM PR Newswire
Law Offices of Howard G. Smith Announces Continued Investigation of ISTA Pharmaceuticals, Inc.
Mar 28, 1:51PM Business Wire
Mar 28, 1:51PM Business Wire
Glancy Binkow & Goldberg LLP Announces Continued Investigation of ISTA Pharmaceuticals, Inc.
Mar 27, 7:00PM Business Wire
Mar 27, 7:00PM Business Wire
Holzer Holzer & Fistel, LLC Announces Investigation into the Proposed Buyout of ISTA Pharmaceuticals, Inc.
Mar 27, 4:01PM Business Wire
Mar 27, 4:01PM Business Wire
News related to $ISTA, currently 0.0% since open: 'Ista rises on Bausch & Lomb buyout offer' http://stks.co/36Aw
about 64 days ago by TradeBot
about 64 days ago by TradeBot
$AFFY or $AMRN : better buy? sold my $ISTA and want to put all my eggs in one basket...not smart but rather not buy both ...taking votes now
about 96 days ago by Creyedr
about 96 days ago by Creyedr
Listen to $ISTA ISTA Pharmaceuticals's Fourth Quarter and Full-Year 2011 Financi - live at 04:30 PM, ondemand after - http://stks.co/2XNt
about 97 days ago by earningscast
about 97 days ago by earningscast
Canada's Valeant withdraws bid for ISTA Pharmaceuticals (Prescription filled, headache gone) $VRX $VRX.CA $ISTA http://stks.co/29De
about 121 days ago by michaelbabad
about 121 days ago by michaelbabad
$ISTA Board Says Reiterates Commitment to Maximizing Shareholder Value Through Strategic Review Process
about 121 days ago by Benzinga
about 121 days ago by Benzinga
RT @Street_Insider $VRX withdraws offer for $ISTA, citing lack of progress
about 121 days ago by ChiBullsTrader
about 121 days ago by ChiBullsTrader
Listened to the $ISTA call. For 2013 they are suggesting adjusted cash EPS > $1.00. Very aggressive projection in light of the $VRX drama.
about 146 days ago by bradloncar
about 146 days ago by bradloncar
$ISTA Guides 2012 EPS $0.28-$0.36 vs $0.39 Est; Revs $180M-$195M vs $195.67M Est
about 147 days ago by Benzinga
about 147 days ago by Benzinga
Listen to $ISTA 2012 Guidance and Pipeline Update - live at 04:30 PM, ondemand after - http://stks.co/1lzv
about 147 days ago by earningscast
about 147 days ago by earningscast
$ISTA Higher After Rejection of Unsolicited, Non-Binding Proposal From $VRX
about 166 days ago by Benzinga
about 166 days ago by Benzinga
ISTA Pharmac $ISTA Rejects Unsolicited $6.50/Share Valeant $VRX Offer
about 166 days ago by Street_Insider
about 166 days ago by Street_Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ISTA | 9.095 | -0.01 | -0.05% | 380.11M |
| IST | 20.56 | -0.20 | -0.96% | |
| ISSI | 9.63 | -0.17 | -1.73% | 264.99M |
| ISSC | 3.54 | -0.05 | -1.39% | 58.91M |
| ISS | 6.28 | -0.46 | -6.82% | 375.89M |
| ISRL | 77.25 | -4.40 | -5.39% | 222.09M |
| ISRG | 520.66 | -7.24 | -1.37% | 20.92B |
| ISR | 1.27 | +0.10 | +8.55% | 34.30M |
| ISNS | 5.17 | -0.14 | -2.64% | 25.38M |
| ISLE | 5.14 | -0.18 | -3.38% | 207.37M |
